Skip to content

HIV Engagement and Adolescent Depression Support (HEADS-UP)

HIV Engagement and Adolescent Depression Support (HEADS-UP)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06173544
Acronym
HEADS-UP
Enrollment
106
Registered
2023-12-15
Start date
2024-07-06
Completion date
2025-10-22
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Behavior, Anxiety, Depression, HIV Infections, Immune System Diseases

Brief summary

This pilot study will individually randomize 105 adolescents living with HIV 1:1:1 to standard of care, adapted intervention, or enhanced intervention. The intervention is called the Friendship Bench Intervention is a counseling intervention for depression and engagement in HIV care.

Detailed description

Sub-Saharan Africa is home to the largest population of adolescents living with HIV (ALWH). Engaging ALWH in HIV care is challenging and reflected in lower rates of viral suppression and higher rates of loss to follow-up as compared to adults in the region. Depression has been identified as a significant barrier to initiating and remaining in HIV care. Indeed, this is the case for ALWH in Malawi where estimates of viral suppression range from 40%-78% and estimates of depression range from 18-26%. Resource-appropriate interventions that improve depression and address engagement in HIV care for ALWH are urgently needed. The Friendship Bench (FB) is an evidence-based depression counseling intervention delivered by trained, supervised lay health workers. It is proven to reduce depression in the general population in low-resource settings but has not been adapted to be youth-friendly or enhanced with peer support to facilitate engagement in HIV care among ALWH. FB is based on problem-solving therapy, which offers an ideal framework for youth-friendly adaption and integration of retention peer support into a proven depression treatment model. The long-term goal of the study team is to adapt, test, and scale up resource-appropriate interventions to reduce depression and improve engagement in HIV care amongst ALWH. The specific aims are: 1) to conduct formative research for youth-friendly adaptation and peer support enhancement of FB; 2) to adapt the evidence-based FB protocol to meet the developmental and contextual needs of ALWH and enhance this adapted FB protocol with peer support to facilitate HIV care engagement among ALWH; and 3) to determine the feasibility, fidelity, and acceptability of the Adapted and Enhanced FB protocols to improve depression and engagement in HIV care among ALWH. For the latter, a 3-arm individually randomized pilot study will be conducted to compare the adapted FB and the enhanced FB to standard care. The proposed aims pave the way for a R01 application to test the adapted and enhanced Friendship Bench interventions in a cluster randomized controlled trial and represent an important step forward towards improving depression among ALWH.

Interventions

BEHAVIORALStandard of Care (SOC)

Participants randomized to this arm will received enhanced standard of care.

BEHAVIORALAdapted Friendship Bench (AFB)

Participants randomized to this arm will receive the Adapted Friendship Bench protocol delivered by a trained counselor.

BEHAVIORALEnhanced Friendship Bench (EFB)

Participants randomized to this arm will receive the Enhanced Friendship Bench protocol delivered by a trained counselor and a peer supporter.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER
RTI International
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Three-Arm Individually Randomized Trial

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* age 13-18 * diagnosed with HIV (vertically or horizontally) * scored ≥ 13 on the self-reported and previously used BDI-II * living in the clinic's catchment area with intention to remain for \> 1 year * willing to provide consent (age 18 or 16-17 years old and married (emancipated minors per Malawi law) or assent with parental consent (age 13-17)

Exclusion criteria

* Less than 13 or greater than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Recruitment Rate (Intervention Feasibility)BaselineThis measure is the ability to successfully enroll adolescents living with HIV (ALWH) in the pilot trial. Feasibility will be evaluated by measuring the recruitment rate (number of patients approached in order to accrue the final sample).
Number of participants retained in the study (Intervention Feasibility)12 monthsThis measure of feasibility will be measured as the ability to retain adolescents living with HIV (ALWH) in the pilot trial. Feasibility will be evaluated by measuring the number of participants retained in the study (number of patients enrolled at baseline who are still enrolled in the trial), through study completion.
Proportion of sessions attended (Intervention Feasibility)12 MonthsThe number of sessions attended by participants out of total number of sessions offered.
Number of sessions meeting Fidelity Threshold (Intervention Fidelity)12 MonthsFidelity to content for sessions will be assessed by a member of the research team using a checklist of intervention characteristics. Intervention fidelity will be measured as the total number of sessions meeting or exceeding expectations for at least 80% of the total number of fidelity checklist items assessed per session.
Overall Satisfaction among Participants (Intervention Acceptability)12 MonthsAcceptability will be assessed through brief exit interviews with a sample of adolescents living with HIV (ALWH), all study staff, and supervisors. Exit interviews will assess how easy the intervention was to participate in or deliver, the perceived usefulness of the intervention, suggestions for improvement, and will explore contextual factors that impeded or facilitated implementation. Intervention acceptability will be measured as the number of participants who were either very satisfied or somewhat satisfied with the intervention. Satisfaction will be measured on a 4-point Likert scale-- 1 indicates high satisfaction and 4 indicates high dissatisfaction.

Secondary

MeasureTime frameDescription
Change in depression symptoms from baselineBaseline,12 monthsChange in depression symptoms from baseline will be evaluated using Beck's Depression Inventory (BDI-II). The Beck Depression Inventory (BDI-II) is a 21-item patient self-report measure of the severity of depression. Each item is rated on a 4-point scale ranging from 0 to 3. The minimum total score is zero and the maximum total score is 63. A total score of 0-13 is considered nondepressed, 14-19 represents mild depression, 20-28 represents moderate depression, and 29-63 represents severe depression. Lower scores represent better outcomes. Scores reported are change in symptoms relative to baseline.
Number of adolescents living with HIV who attended at least one appointment per quarter12 monthsNumber of adolescents living with HIV who attended at least one appointment per quarter.
Number of Participants Achieving HIV Viral Suppression12 monthsNumber of participants achieving HIV viral suppression at 12 months (HIV RNA \< 1000 copies/mL).

Countries

Malawi

Contacts

PRINCIPAL_INVESTIGATORBradley N Gaynes, MD

University of North Carolina, Chapel Hill

PRINCIPAL_INVESTIGATORNivedita L Bhushan, PhD

RTI International

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026